Showing results (671-680 of 896) with videos related to
Sort By:
Pageof 90
Bone|June 23, 2004
Bone biomechanical properties in LRP5 mutant miceM P Akhter, D J Wells, S J Short, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary CancersMarinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, et al.Journal of Multidisciplinary Healthcare|May 26, 2022
A Qualitative Study of Older Adults' Experiences of Embedding Physical Activity Within Their Home Care Services in IrelandElissa Burton, N Frances Horgan, Vanda Cummins, et al.European Urology Focus|November 27, 2025
A Systematic Review and Meta-analysis of Oncological Outcomes of Treated and Untreated Complex Cystic Renal MassesFederica Sordelli, Hannah Warren, Namir Khalil, et al.Clinical Interventions in Aging|March 18, 2022
Embedding Physical Activity Within Community Home Support Services for Older Adults in Ireland - A Qualitative Study of Barriers and EnablersLauren Swan, N Frances Horgan, Vanda Cummins, et al.Urology|August 12, 2020
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert InquiryKatharina Boehm, Anita Thomas, Axel Bex, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2003
High bone mass in mice expressing a mutant LRP5 genePhilip Babij, Weiguang Zhao, Clayton Small, et al.European Urology Oncology|June 7, 2025
Quality Indicators for Renal Cancer Care: A Systematic ReviewAlessio Pecoraro, Sara Costagli, Laura Marandino, et al.BJU International|September 24, 2013
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy aloneLaura S Mertens, Richard P Meijer, Wim Meinhardt, et al.Frontiers in Endocrinology|October 25, 2023
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's diseaseRichard A Feelders, Maria Fleseriu, Pinar Kadioglu, et al.Pageof 90